arrow
N

Natacha Naoun

gustave roussy
H指数:9
被引数:260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PSMA-targeted radioligand therapy with beta emitters in prostate cancer: current evidence, emerging indications, combination strategies, and future directions

PSMA靶向放射性配体疗法在前列腺癌中的应用:当前证据、新兴适应症、联合策略及未来方向

2026-09-280
OA
Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: results from the first-in-human STESIDES study

ODM-209类固醇生成抑制剂用于转移性去势抵抗性前列腺癌和晚期乳腺癌:来自首次人体STESIDES研究的结果

2026-09-120
PRE
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration- resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study

先前接受卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的177前列腺特异性膜抗原活性和预后决定因素: PACAP研究

2024-10-010
OA
Microbiota-related multiomics to assess the clinical relevance of antibiotics (ATB) in immunotherapy (ICI)

微生物组相关多组学评估抗生素(ATB)在免疫治疗(ICI)中的临床相关性

2024-09-011
PRE
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer

去势抵抗性前列腺癌侵袭性变异体新模型的建立

2024-06-011
PRE
Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal single-cell analysis of patient tumors identifies biological correlates of response to PARP inhibitors and anti-PD-L1 therapy
2024-03-220
PRE
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study
2023-11-011
PRE
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study
2023-03-012
OA
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer
DRUGS
IF14.4
2022-05-0513
PRE